Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanwei Chen

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Medicinal Chemistry|September 17, 2024
Discovery of orally bioavailable ALK PROTACs based ceritinib against ALK positive cancersHaoxuan Zhou, Mingxing Hu, Hui Jie, et al.
Iscience|October 9, 2024
Platelet factors ameliorate thoracic aortic aneurysm and dissection by inhibiting the FGF-FGFR cascade activation in aortic-endothelial cellJizhong Wang, Caiyun He, Yuanwei Chen, et al.
Pharmacological Research|January 11, 2011
EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c) levels in db/db mice and prolongs the survival of stroke-prone ratsWenbin Zhang, Ajith Welihinda, Jordan Mechanic, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitorsBinhua Lv, Baihua Xu, Yan Feng, et al.
Bioorganic & Medicinal Chemistry|June 26, 2010
ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitorsBaihua Xu, Yan Feng, Binhua Lv, et al.
Journal of Medicinal Chemistry|January 25, 2014
Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetesGe Xu, Binhua Lv, Jacques Y Roberge, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2011
C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetesBaihua Xu, Yan Feng, Huawei Cheng, et al.
Biochemistry|January 22, 2003
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor seriesVincent Stoll, Kent D Stewart, Clarence J Maring, et al.
Pulmonary Circulation|May 6, 2022
Visibility, wind speed, and dew point temperature are important factors in SARS-CoV-2 transmissibilityDansha Zhou, Elizabeth W Wang, Chi Hou, et al.
Signal Transduction and Targeted Therapy|April 12, 2026
Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trialJunlong Wu, Xinghai Li, Chengyuan Gu, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Medicinal Chemistry|September 17, 2024
Discovery of orally bioavailable ALK PROTACs based ceritinib against ALK positive cancersHaoxuan Zhou, Mingxing Hu, Hui Jie, et al.
Iscience|October 9, 2024
Platelet factors ameliorate thoracic aortic aneurysm and dissection by inhibiting the FGF-FGFR cascade activation in aortic-endothelial cellJizhong Wang, Caiyun He, Yuanwei Chen, et al.
Pharmacological Research|January 11, 2011
EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c) levels in db/db mice and prolongs the survival of stroke-prone ratsWenbin Zhang, Ajith Welihinda, Jordan Mechanic, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitorsBinhua Lv, Baihua Xu, Yan Feng, et al.
Bioorganic & Medicinal Chemistry|June 26, 2010
ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitorsBaihua Xu, Yan Feng, Binhua Lv, et al.
Journal of Medicinal Chemistry|January 25, 2014
Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetesGe Xu, Binhua Lv, Jacques Y Roberge, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2011
C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetesBaihua Xu, Yan Feng, Huawei Cheng, et al.
Biochemistry|January 22, 2003
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor seriesVincent Stoll, Kent D Stewart, Clarence J Maring, et al.
Pulmonary Circulation|May 6, 2022
Visibility, wind speed, and dew point temperature are important factors in SARS-CoV-2 transmissibilityDansha Zhou, Elizabeth W Wang, Chi Hou, et al.
Signal Transduction and Targeted Therapy|April 12, 2026
Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trialJunlong Wu, Xinghai Li, Chengyuan Gu, et al.
Pageof 11